| 常用名 | (4-(双(4-氯苯基)甲基)哌嗪-1-基)(5-甲基-4-硝基异恶唑-3-基)甲酮 | CAS号 | 1360705-96-9 |
|---|---|---|---|
| 价格 | 纯度 | 98.0% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: ML-210,the most potent compound in the nitroisoxazole series, is a selective covalent inhibitor of glutathione peroxidase 4 (GPX4) by binding the selenocysteine residue[1]. ML-210 has IC50s of 71 nM, 272 nM and 107nM for BJeLR (HRASV12), BJeH-LT (without HRASV12) and DRD cell lines, respectively[2]. 物理化学性质: CAS号:1360705-96-9 常用中文名:(4-(双(4-氯苯基)甲基)哌嗪-1-基)(5-甲基-4-硝基异恶唑-3-基)甲酮 常用英文名:ML 210 分子式:C22H20Cl2N4O4 分子量:475.325 密度:1.4±0.1 g/cm3 沸点:644.7±55.0 °C at 760 mmHg 熔点:N/A 闪点:343.7±31.5 °C 储存条件:2-8°C,密闭,干燥 |